Fundz

Biomapas acquires Alira Health’s CMC business

Nov 16, 2026

Acquiring Company

Biomapas

Acquired Company

X Cor Therapeutics

LithuaniaFraminghamBiotechnologyHealth Care

Description

Biomapas has entered the US market by acquiring the CMC business of Alira Health. This acquisition allows Biomapas to establish its new North America business and enhance its service offerings to support clients in the biopharmaceutical sector.

Other recent acquisitions in Biotechnology and Health Care

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Biomapas, and when

When Biomapas changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Biomapas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biomapas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biomapas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biomapas

Location

Lithuania

About

Biomapas is a Lithuanian-headquartered life sciences services provider. The company operates across clinical trials, pharmacovigilance, medical information, regulatory affairs and medical writing. Biomapas aims to build a diversified pharma services platform with revenue of more than €200 million, driven by a mix of organic expansion and acquisitions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biomapas makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tadas
Senior decision-maker at this company
••••••••@••••••••

See Tadas's verified email →

Petras
Likely contact at this company
••••••••@••••••••

See Petras's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Biomapas's next move

Learn about Strategic plan

Frequently asked

Who acquired X Cor Therapeutics?

X Cor Therapeutics was acquired by Biomapas, based in Lithuania. The deal was reported on November 16, 2026. Biomapas is a Lithuanian-headquartered life sciences services provider. The company operates across clinical trials, pharmacovigilance, medical information, regulatory affairs and medical writing. Biomapas is privately held and operates in Biotechnology.

When did Biomapas acquire X Cor Therapeutics?

Biomapas's acquisition of X Cor Therapeutics was reported on November 16, 2026. Biomapas has entered the US market by acquiring the CMC business of Alira Health. This acquisition allows Biomapas to establish its new North America business and enhance its service offerings to support clients in the biopharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does X Cor Therapeutics do?

Alira Health is an international patient-centric and technology-enabled advisory firm on the frontlines of healthcare transformation. It is privately held, and is based in Framingham.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.